Modulation of the expression of matrix metalloproteinase and tissue inhibitors of metalloproteinases by TGF-β1 and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-α

被引:48
|
作者
Hui, W [1 ]
Rowan, AD [1 ]
Cawston, T [1 ]
机构
[1] Newcastle Univ, Sch Med, Dept Rheumatol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
cartilage; collagen; IGF-1; TGFbeta; TNFalpha;
D O I
10.1006/cyto.2001.0950
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumour necrosis factor-alpha (TNF-alpha) was able to promote collagen breakdown from bovine cartilage in explant culture. This release was dependent upon matrix metalloproteinases (MMPs) and could be prevented by transforming growth factor-beta1 (TGF-beta1) or insulin-like growth factor-1. Both growth factors reduced the expression and secretion of collagenase enzymes, and TGF-beta1 induced tissue inhibitor of metalloproteinase production. This study shows for the first time that these anabolic growth factors can protect cartilage against TNF-alpha -induced destruction. (C) 2001 Academic Press.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 50 条
  • [31] PEP-1-GRX-1 Modulates Matrix Metalloproteinase-13 and Nitric Oxide Expression of Human Articular Chondrocytes
    Hwang, Hyun Sook
    Park, In Young
    Choi, Soo Young
    Kim, Hyun Ah
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (01) : 252 - 264
  • [32] Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas
    Maeta, H
    Ohgi, S
    Terada, T
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 2001, 438 (02): : 121 - 128
  • [33] Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas
    Hiroyuki Maeta
    Shigetsugu Ohgi
    Tadashi Terada
    Virchows Archiv, 2001, 438 : 121 - 128
  • [34] Matrix metalloproteinases-2,-7 and tissue metalloproteinase inhibitor-1 expression in human endometrium
    Grzechocinska, Barbara
    Dabrowski, Filip A.
    Cyganek, Anna
    Chlebus, Marcin
    Kobierzycki, Christopher
    Michalowski, Lukasz
    Gornicka, Barbara
    Wielgos, Miroslaw
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2018, 56 (03) : 133 - 140
  • [35] Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-α in human osteoarthritic chondrocytes
    Nah, Seong-Su
    Choi, In-Young
    Yoo, Bin
    Kim, Yong Gil
    Moon, Hee-Bom
    Lee, Chang-Keun
    FEBS LETTERS, 2007, 581 (09): : 1928 - 1932
  • [36] TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATES TISSUE INHIBITOR OF METALLOPROTEINASES-1 EXPRESSION IN DIFFERENTIATED HUMAN ARTICULAR CHONDROCYTES
    GUNTHER, M
    HAUBECK, HD
    VANDELEUR, E
    BLASER, J
    BENDER, S
    GUTGEMANN, I
    FISCHER, DC
    TSCHESCHE, H
    GREILING, H
    HEINRICH, PC
    GRAEVE, L
    ARTHRITIS AND RHEUMATISM, 1994, 37 (03): : 395 - 405
  • [37] Chondroprotective effects of a proanthocyanidin rich Amazonian genonutrient reflects direct inhibition of matrix metalloproteinases and upregulation of IGF-1 production by human chondrocytes
    Miller M.J.S.
    Bobrowski P.
    Shukla M.
    Gupta K.
    Haqqi T.M.
    Journal of Inflammation, 4 (1)
  • [38] TGF-β1 protects OA, but not normal, human chondrocytes from Ro 31 8220 and TNF-α-induced apoptosis.
    Lires-Deán, M.
    López-Armada, M. J.
    Caramés, B.
    Cillero-Pastor, B.
    Lema, B.
    Blanco, F. J.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S72 - S72
  • [39] Induction of matrix metalloproteinase-13 gene expression by TNF-α is mediated by MAP kinases, AP-1, and NF-κB transcription factors in articular chondrocytes
    Liacini, A
    Sylvester, J
    Li, WQ
    Huang, WS
    Dehnade, F
    Ahmad, M
    Zafarullah, M
    EXPERIMENTAL CELL RESEARCH, 2003, 288 (01) : 208 - 217
  • [40] TGF-β1 and IGF-1 expression are differently regulated by serum in metastatic and non-metastatic human breast cancer cells
    Perlino, E
    Tommasi, S
    Moro, L
    Bellizzi, A
    Marra, E
    Casavola, V
    Reshkin, SJ
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 16 (01) : 155 - 160